Migdal Insurance & Financial Holdings’s Virtus Biotech ETF BBP Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio BBP Stock Details BBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,780	Closed	-$136K	–	502
2023 Q1	$136K	Hold	2,780	–	–	﹤0.01%	290
2022 Q4	$136K	Hold	2,780	–	–	﹤0.01%	239
2022 Q3	$125K	Hold	2,780	–	–	﹤0.01%	242
2022 Q2	$115K	Hold	2,780	–	–	﹤0.01%	291
2022 Q1	$121K	Hold	2,780	–	–	﹤0.01%	328
2021 Q4	$137K	Buy	+2,780	New	+$138K	﹤0.01%	327
2019 Q1	–	Sell	-965	Closed	-$34K	–	700
2018 Q4	$34K	Hold	965	–	–	﹤0.01%	580
2018 Q3	$44K	Buy	965 +615	+176%	+$27.5K	﹤0.01%	703
2018 Q2	$15K	Buy	+350	New	+$14.8K	﹤0.01%	723

Other funds holding BBP

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FEM

Fulcrum Equity Management Plano, Texas $136M AUM 42.95% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

LCGC

Legacy Capital Group California Los Gatos, California $332M AUM 42.15% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

DSC

Duncker Streett & Co St. Louis, Missouri $591M AUM 26.48% 1-Year Est. Return

Migdal Insurance & Financial Holdings's BBP Position: Q2 2023 in Review

Migdal Insurance & Financial Holdings sold out of Virtus Biotech ETF (BBP) in Q2 2023, closing a stake of 2,780 shares — an estimated $136K sold.

Migdal Insurance & Financial Holdings first reported a position in BBP in Q2 2018 and held it in 9 quarters. The position peaked at $137K in Q4 2021. 13 funds tracked by Wall St. Rank hold BBP as of Q2 2023.

Migdal Insurance & Financial Holdings reported no remaining Virtus Biotech ETF position as of Q2 2023 after selling out during the quarter.
Migdal Insurance & Financial Holdings sold 2,780 Virtus Biotech ETF shares in Q2 2023, an estimated $136K.
Migdal Insurance & Financial Holdings first reported a position in Virtus Biotech ETF in Q2 2018 and held it in 9 quarters.
Migdal Insurance & Financial Holdings's Virtus Biotech ETF position peaked at $137K in Q4 2021.
13 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q2 2023.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2023, filed 24 Jul 2023.